ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia.

Isere Kuiatse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.